Manulife (Manufacturers Life Insurance)’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $141K | Sell |
61,005
-2,792
| -4% | -$6.45K | ﹤0.01% | 2677 |
|
|
2025
Q1 | $88.7K | Buy |
63,797
+786
| +1% | +$1.09K | ﹤0.01% | 2724 |
|
|
2024
Q4 | $109K | Buy |
63,011
+2,346
| +4% | +$4.06K | ﹤0.01% | 2800 |
|
|
2024
Q3 | $122K | Sell |
60,665
-72,548
| -54% | -$146K | ﹤0.01% | 2814 |
|
|
2024
Q2 | $298K | Buy |
133,213
+69,487
| +109% | +$156K | ﹤0.01% | 2425 |
|
|
2024
Q1 | $183K | Buy |
63,726
+2,179
| +4% | +$6.25K | ﹤0.01% | 2626 |
|
|
2023
Q4 | $109K | Hold |
61,547
| – | – | ﹤0.01% | 2793 |
|
|
2023
Q3 | $194K | Buy |
+61,547
| New | +$194K | ﹤0.01% | 2619 |
|
|
2022
Q2 | – | Sell |
-11,233
| Closed | -$73.2K | – | 3142 |
|
|
2022
Q1 | $73.2K | Sell |
11,233
-1,731
| -13% | -$11.3K | ﹤0.01% | 3005 |
|
|
2021
Q4 | $151 | Buy |
12,964
+650
| +5% | +$8 | ﹤0.01% | 2986 |
|
|
2021
Q3 | $229K | Sell |
12,314
-651
| -5% | -$12.1K | ﹤0.01% | 2886 |
|
|
2021
Q2 | $275K | Buy |
+12,965
| New | +$275K | ﹤0.01% | 2875 |
|